January 21, 2020 by Chain Drug Review
CVS Pharmacy, Department of Health and Human Services, Rite Aid Corp., Walgreens
January 20, 2020, News
WASHINGTON — Walgreens, CVS Pharmacy and Rite Aid Corp. have donated dispensing services for the Department of Health and Human Services’ (HHS’) new program expanding access to medication to prevent HIV. Beginning no later than March 30, as part of these donations, qualified patients can obtain medications for pre-exposure prophylaxis (PrEP) at more than 21,000
October 23, 2018 by Stephanie Kennan
Department of Health and Human Services, Medicaid, Opioid
Issue 10-22-2018
Routine monitoring of medication adherence is one of the Medicaid programs that must be included under a new law passed by Congress in response to the opioid epidemic. The recently passed opioid legislation makes improvements in treatment capacity for Medicaid patients. However, the legislation has significance for the pharmacy industry because it directs the Department
October 16, 2018 by Chain Drug Review
Department of Health and Human Services, drug companies to disclose the list price of prescription drugs in television ads, J.C. Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement on the Department of Health and Human Services’ proposal requiring drug companies to disclose the list price of prescription drugs in television ads: “We share the Administration’s goal of reducing prescription drug prices. Pharmacy benefit managers (PBMs) foster competition among drugmakers, resulting
April 4, 2018 by Bill Schiffner
Department of Health and Human Services, Mark Merritt, Medicare Part D, Pharmaceutical Care Management Association
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on the Medicare Part D final rule released this week by the Department of Health and Human Services: “Two years ago drugmakers launched a campaign to deflect blame for their high prices onto health plans and pharmacy benefit
October 23, 2017 by Chain Drug Review
Buddy Carter, Centers for Medicare & Medicaid Services, Department of Health and Human Services, DIR fees, Don Wright, Medicare Part D, NASP, National Association of Specialty Pharmacy, Seema Verma, Sheila Arquette, StopDIRfees.com
2017, Issue 10-23-2017, Issues, Opinion
WASHINGTON — The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers. The lawmakers sent a letter to the Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid
August 19, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HealthCare.gov, Julie Mix McPeak, Lamar Alexander, Michael Consedine, Mitch McConnell, National Association of Insurance Commissioners, Obamacare, President Donald Trump, skinny repeal
2017, Issue 08-21-2017, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The failed effort to overturn the Affordable Care Act has hardly erased doubts about the law’s short- and long-term viability. Already, the Trump administration has suspended contracts with two companies that have helped thousands of people in nearly a score of cities get health insurance under the statute. In ending the $22 million
June 15, 2017 by Chain Drug Review
2018 HHS budget, Access Agenda, Department of Health and Human Services, Enhanced MTM Model, H.R. 592, NACDS, National Association for Chain Drug Stores, Pharmacy and Medically Underserved Areas Enhancement Act, S. 109
Leading Headlines, Retail News
ARLINGTON, Va. — The National Association for Chain Drug Stores moved its Access Agenda platform forward with comments to Congress as committees consider the fiscal 2018 budget for the Department of Health and Human Services (HHS). NACDS said Thursday that it submitted statements highlighting pro-patient health care solutions as the Senate Finance Committee and the
June 5, 2017 by Greg Jacobson and Chain Drug Review
Centers for Disease Control and Prevention, cuts in health care, Department of Health and Human Services, fiscal 2018 U.S. budget, Food and Drug Administration, Mick Mulvaney, National Institutes of Health
2017, Issue 06-05-2017, Issues, News
WASHINGTON — The fiscal 2018 U.S. budget issued by the Trump administration calls for steep cuts in health care and scientific research while heavily boosting defense spending and offering substantial tax cuts. Dubbed “A New Foundation for American Greatness,” the spending plan was touted as a “taxpayer first” budget by Mick Mulvaney, director of the
February 6, 2017 by Scot Meyer and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HHS secretary, Orrin Hatch, Tom Price, Trump administration
2017, Issue 02-06-2017, Issues, News
WASHINGTON — Tom Price, an orthopedic surgeon, a six-term Republican congressman from Georgia and a fierce critic of the Affordable Care Act, faced tough questions from Democrats about ethical issues and policy priorities during his confirmation hearing. But at presstime it appeared that he would be approved as Secretary of the Department of Health and
February 1, 2017 by CDR Blog and Chain Drug Review
American Pharmacists Association, APhA, Department of Health and Human Services, Donald Trump, HHS secretary nominee, Pharmacy and Medically Underserved Areas Enhancement Act, provider status, Tom Menighan, Tom Price
CDR Blog
Rep. Tom Price (R., Ga.) had a tense confirmation hearing in the Senate last week for his nomination by President Donald Trump as secretary of the Department of Health and Human Services (HHS). But he got a thumbs-up from the American Pharmacists Association (APhA) on at least one count: pharmacists’ place in the U.S. health
January 2, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, Andy Slavitt, Centers for Medicare & Medicaid Services, Council of Economic Advisers, Department of Health and Human Services, health insurance, Jason Furman, Kevin Brady, Obamacare, President-elect Donald Trump’s inauguration, Sylvia Burwell
2017, Issue 01-02-2017, Issues, News
WASHINGTON — Republicans want to replace the Affordable Care Act with “universal access” to health care, House GOP members said. The goal is to ensure that everyone can buy or find coverage, a House leadership aide said at a briefing organized by top Republicans. The briefing came amid growing concern about the 20 million people
January 2, 2017 by Chain Drug Review
Department of Health and Human Services, National Association of Chain Drug Stores, pharmacy customer rewards programs, reward and loyalty programs, Steve Anderson
2017, Issue 01-02-2017, Issues, News
WASHINGTON — The National Association of Chain Drug Stores welcomed a final rule issued by the Department of Health and Human Services (HHS) that allows pharmacies greater flexibility to extend their reward and loyalty programs to beneficiaries in government programs, including Medicare and Medicaid. NACDS said Wednesday that the final rule, issued by HHS’ Office
December 14, 2016 by Chain Drug Review
Department of Health and Human Services, HHS Office of the Inspector General, NACDS, National Association of Chain Drug Stores, pharmacy customer rewards programs, Steve Anderson
Leading Headlines, Retail News
ARLINGTON, Va. — The Department of Health and Human Services (HHS) is giving pharmacies more flexibility to extend their reward and loyalty programs to beneficiaries in government programs such as Medicare and Medicaid, according to the National Association of Chain Drug Stores. NACDS said Wednesday that the final rule, issued by the HHS Office of
December 12, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, Department of Health and Human Services, Donald Trump, HHS, National Association of Chain Drug Stores, Obamacare, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The choices of Tom Price and Seema Verma for top health positions under Donald Trump have reaffirmed the president-elect’s commitment to toppling the Affordable Care Act. Price, a six-term Republican congressman from Georgia and fierce critic of Obamacare, was picked as secretary of the Department of Health and Human Services (HHS), while Verma,